UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
SCHEDULE 14A INFORMATION
INFORMATION STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. ___)
Filed by the registrant [X]
Filed by a party other than the registrant [ ]
Check the appropriate box:
[ ] Preliminary Information Statement
[ ] Confidential, for use of the Commission only (as permitted by
Rule 14a-6(e)(2)).
[ ] Definitive proxy statement.
[X] Definitive additional materials.
[ ] Soliciting material under Rule 14a-12.
ENDOVASC, INC.
(Name of Registrant as Specified in its Charter)
------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth amount on which
filing fee is calculated and state how it was determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offering fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of the filing.
1) Amount previously paid:
2) Form, Schedule or Registration Statement No.:
3) Filing Party:
4) Date Filed:
[LOGO] ENDOVASC
November 22, 2004
Ladies and Gentlemen:
The Annual Meeting of Stockholders of Endovasc, Inc. on November 19, 2004 was
adjourned for lack of a quorum and will reconvene on December 17, 2004. Our
records indicate that you own shares of Endovasc Common Stock or Endovasc Series
NDC Stock, both of which may vote at the Annual Meeting, and have received a
copy of Management's Proxy Materials. Since we have not received a signed proxy
from you, I have enclosed a copy of Management's Proxy for your signature and
return to me.
Your vote is critical to the continuing operations of the company. We would ask
that you approve Management's request by voting for all three items listed on
the Proxy. However, regardless of how you decide to vote, it is extremely
urgent that you return the enclosed Proxy.
WE URGE YOU TO IMMEDIATELY SIGN AND RETURN THE ENCLOSED MANAGEMENT PROXY IN THE
ENVELOPE PROVIDED.
Please feel free to contact Dwight Cantrell or myself if you have any questions.
Very truly yours
Endovasc, Inc.
/s/ Diane Dottavio
Diane Dottavio, Ph.D.
President and
Chief Executive Officer
550 Club Drive, Suite 440
Montgomery, Texas 77316
P. 936-582-5920 * F. 936-582-5996
www.endovasc.com
ENDOVASC, INC.
ANNUAL MEETING OF STOCKHOLDERS - NOVEMBER 19, 2004
COMMON STOCK AND SERIES NDC COMMON STOCK PROXY
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Melissa Rogers attorney-in-fact and proxy
with full power of substitution to vote, as designated on the reverse side, all
shares of Common Stock, $.001 par value and/or all shares of Series NDC Common
Stock, $.001 par value, of Endovasc, Inc. which the undersigned may be entitled
to vote at the Annual Meeting of Stockholders to be held at 19785 Highway 105
W., Montgomery, TX on November 19, 2004 at 2 pm and any adjournments thereof,
upon all matters which may properly come before said Annual Meeting.
THIS PROXY SHALL BE VOTED IN ACCORDANCE WITH THE INSTRUCTIONS MARKED ON THE
REVERSE SIDE HEREOF. IF NO CHOICE IS MARKED, THE UNDERSIGNED GRANTS THE PROXY
DISCRETIONARY AUTHORITY WITH RESPECT TO THE ELECTION OF DIRECTORS, PROPOSAL 2
AND PROPOSAL 3. UNLESS OTHERWISE SPECIFIED, THIS PROXY WILL BE VOTED FOR THE
ELECTION OF THE NOMINEE LISTED ON THE REVERSE SIDE, FOR PROPOSAL 2 AND FOR
PROPOSAL 3. IN ADDITION, THE UNDERSIGNED GRANTS THE PROXY DISCRETIONARY
AUTHORITY TO VOTE ON ANY MATTER OF WHICH THE COMPANY HAD NOT RECEIVED NOTICE ON
OR BEFORE SEPTEMBER 7, 2004, APPROVAL OF MINUTES OF THE PRIOR ANNUAL MEETING AND
OTHER MATTERS INCIDENT TO THE CONDUCT OF THE ANNUAL MEETING.
Any proxy heretofore given by the undersigned with respect to such stock is
hereby revoked. Receipt of the Notice of the Annual Meeting, Proxy Statement
and Annual Report to Stockholders is hereby acknowledged.
Comments: --------------------------------------------------------------------
- --------------------------------------------------------------------------------
(If you noted any Comments above, please mark corresponding
box on the reverse side.)
(Please date and sign proxy on reverse side and return in enclosed envelope)
ENDOVASC, INC.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE
NOMINEE LISTED BELOW, "FOR" PROPOSAL 2 AND "FOR"
PROPOSAL 3.
Election of a Director
For Withhold For All To withhold authority to vote, mark
All All Except "For All Except" and write the nominees
number on the line below
1.Election of M. Dwight Cantrell as a Director [ ] [ ] [ ] _______________________________
Vote on Proposals For Against Abstain
2.Approval of Ham, Langston & Brezina LLP as independent public [ ] [ ] [ ]
accountants of the Company.
3.Approval of the Amendment to the Articles of Incorporation to increase [ ] [ ] [ ]
the number of shares of Common Stock authorized.
For comments please check this box [ ]
and write them on the back where indicated.
signature must be exactly as the
name of the stockholder appears
on the certificate representing
shares of the Company's stock.
- ------------------------------------ --------- ----------------------------------------------- --------
Signature PLEASE SIGN WITHIN BOX Date Signature (Joint Owners) Date